Shawkea series products have been successfully developed since 1992 by Mr. Shao Hui, a graduate of Beijing University of Traditional Chinese Medicine, who later moved from China to Japan, and obtained a doctorate in medicine from the National Osaka University of Japan. In 1998, Shawkea products were successfully launched in Japan, United States, Malaysia, and other countries and have received an outstanding reputation. Shawkea products began to enter the Chinese market in 2012. As a line of infertility supplementary product, Shawkea has been sold worldwide for 21 years and brought peace to many individuals and families.
Geographical Distribution of Sales:
Shawkea series products have been sold worldwide for 21 years. Exported to Europe, America, Southeast Asia, South Africa, and other countries and regions, Shawkea has helped countless families realize their dreams. With strong scientific evidence and numerous patients’ testimonials, Shawkea has received praise and attention from all over the world.
Agency Distribution:
Japan is a country with high integrity. When each pharmacy introduces a new product, extensive research must be conducted on the efficacy and reputation of the product. The reputation of the pharmacy will be negatively impacted if it fails to do so. Currently, more than 1,200 pharmacies that represent this product are derived from publications on the society, mutual introduction between pharmacies, and word of mouth between patients.
Shawkea products are sold in 1,204 pharmacies and reproduction centers within the 47 prefectures throughout Japan.
Global Sales:
Due to the stable number of agencies and high market recognition, the annual global sales of Shawkea series products are growing at a rate of 30%, especially in the Chinese market. Due to its recognition by well-known academic associations and professional institutions, the visibility of Shawkea products has increased significantly.
The number-one selling fertility supplement in Japan is now available in the United States! Shawkea series products increase the capacity and sensitivity of reproductive hormone receptors, improves the quality and quantity of eggs and sperm and helps create an optimal uterine environment for fertilization.
Group who takes Shawkea products: 725 Patients
(Recommended：Shawkea T-1 9 capsules per day, Pine Knot Extract 6 capsules per day)
Group who did not take Shawkea products: 335 patients
Note：There are 75 people under the age of 29, because the number is relatively small, this time it is not included in the statistics, and will continue to follow the statistics in the future. *1060 patients' data are all from Hanabusa Women's Clinic in Japan with the same variables, which ensures the consistency of the data.
Japanese Society of Integrated Reproductive Medicine
The Japanese Society of Integrated Reproductive Medicine was founded by Hui Shao, M.D., who graduated with a doctorate from the University of Osaka, Japan. Through organizing academic conferences revolving the study of Western Medicine and Traditional Chinese Medicine, this organization trained many pharmacists specializing in infertility treatment combined with Western Medicine and Traditional Chinese Medicine. Academic studies show that, for individuals at an advanced maternal age, by regulating their physical condition before they receive IVF treatment, their physical fitness has been effectively improved, thereby their IVF success rate has significantly improved as well.
This kind of comprehensive early-stage health counseling and treatment, combining Western Medicine with Traditional Chinese Medicine, has become a typical model of fertility treatment in Japan. It has taken the lead in the treatment of infertility around the world. Academic conferences have been held for 13 years, with four sessions per year, and more than 800 registered pharmacists attended.
Published in a Well-known Japanese Magazine
In the "Pregnant Life" section of the well-known Japanese pregnancy magazine Desiring Baby (Pregnant Living), authoritative recommendations on diet and health maintenance for expectant and pregnant mothers were shared, and Shawkea T-1 was recommended.
"I Want a Baby" is published by Japan's famous publishing house "Housewives' Friends.”. This magazine covers everything from conception plans to infertility treatments for different causes. Also, this magazine includes testimonials of fertility patients, a nationwide guide to infertility centers, IVF drugs and costs, and the role of Chinese medicine in infertility treatment.
《STORY》magazine, on December 2015, reported the conception journey of Yoshikawa, a famous Japanese model.
After ten long years of marriage and trying various conception treatment but failed, she became pregnant in less than half a year with the help of Shawkea T-1 and Shawkea moxibustion. In late August of 2015, at the age of 40, she successfully delivered and realized her dream of becoming a mother.
“STORY” is a magazine for new generation women in their 40s. Its readers not only pursue fashion but also pay more attention to their life quality and lifestyle. They don't think "aging equals getting older.” Rather, in their values, aging means beauty. They know fashion trends and are keen to invest in themselves. Shawkea advertisements published in "STORY" have received great feedback from these readers.
Japan's best-selling women's magazine "Beauty ST" made a special report on the hot topic of "pregnancy of women in their 40s.” After interviewing female celebrities who became pregnant at 40 years old and older, it was found that Shawkea T-1 and the Shawkea moxibustion device, played an important role in reducing coldness in extremities, improving blood circulation, and increasing pregnancy rate.
"Beauty ST" is a monthly magazine issued by the Kwang Bun publishing house in Japan. It is undeniable that aging brings changes to the skin. This magazine has published a lot of beauty information for women to become youthful and beautiful. The magazine also covers tips in daily life and easy-to-learn cosmetology.
Shawkea T-1 was accredited as a safe and high-quality medicine in the 2016 New Year's Health Special Feature in Sunday Every Day Magazine.
“Sunday Every Day” is published by the Daily News-Press and is the first comprehensive weekly publication in Japan. This magazine dissects and analyzes current political, economic, and social issues.
"Pregnant Life" featured a story on a New Year's Day pregnancy. Shawkea T-1 was rated as the most effective pregnancy preparation product.
"Pregnant Life" was published by the famous Japanese publishing house "Housewives' Friends.” The magazine provides an easy-to-understand introduction to hospital choices, diet, and sports. It is the best guide for women to prepare for their pregnancy.
World-renowned fashion magazine "ELLE" promotes the Shawkea moxibustion device:
ELLE is a well-known women’s fashion magazine, that focuses on fashion, beauty, and lifestyle. Launched in France in 1945, the international magazine has an amazing expansion capacity of 70 copies, representing the strength of French Huaxia Group.
The Japanese Yomiuri TV station conducted a special interview with Shawkea moxibustion device and broadcasted it during primetime among 28 provinces and cities in Japan, which received great feedback. During the show, many well-known female artists experienced the charm of Shawkea moxibustion by applying it on their ears. The Yomiuri National Television of Japan was established on February 13, 1958, by the Osaka Yomiuri Shimbun (owned by Yomiuri Shimbun), and renamed the Yomiuri Television on August 1st of the same year. "Yomiuri Shimbun" is a national newspaper in Japan with considerable influence. It was published in Tokyo on November 2, 1874. In 2003, it had a daily circulation of more than 14 million copies. It ranked first in the world's daily newspaper circulation and was included in the Guinness Book of World Records.
On September 4, 2016, the Academic Conference of the Reproductive Endocrinology and Perinatal Medicine Professional Committee of the Beijing Society of Integrated Chinese and Western Medicine was held in Beijing Obstetrics and Gynecology Hospital, Capital Medical University. As a well-known figure in the field of reproductive endocrinology in the integration of traditional Chinese and Western medicine, Professor Hui Shao, professor at Hanabusa Women’s Clinic and inventor of Shawkea T-1, was the only expert invited from overseas.. Dr. Shao has dedicated himself in improving egg quality fundamentally in older women with the safest approach.
Between December 23-24, 2015, the Ninth National Academic Conference on Reproductive Medicine of the Chinese Medical Association was successfully held in Zhengzhou, Henan. A total of about 1,500 reproductive medicine experts from China and abroad participated in the discussion on new developments and hot issues in reproductive medicine, such as assisted reproductive technology, and diseases affecting reproductive functions. Dr. Hui Shao, the inventor of Shawkea products, was invited to participate in the conference and share his scientific studies.
On November 17, 2016, the 10th National Conference on Reproductive Medicine of the Chinese Medical Association, sponsored by China’s Medical Association and the Reproductive Medicine Branch of the Chinese Medical Association, was held at Xi'an Qujiang International Conference Center. Thousands of reproductive medicine experts participated in the conference. Dr. Hui Shao, a well-known reproductive medicine expert in the field of integration of Traditional Chinese and Western Medicine, and inventor of Shawkea T-1, was also invited to participate in the meeting. His paper on Shawkea T-1’s effect on increasing hormone secretion and increasing the number of ovulations in older mice stood out from thousands of papers and was selected for the poster exhibition of the conference. It presented the latest research results to many reproductive experts, but also provided a brand-new approach to treatment of premature ovarian failure.
Between March 9-11, 2018, the National Reproductive Endocrine of New Development and New Concept Symposium was successfully held in Guangzhou. It was co-sponsored by the Guangdong Provincial Physician Association of Obstetricians and Gynecologists and Sun Yixian Memorial Hospital of Sun Yixian University. Dr. Shiotani, a well-known expert in reproductive medicine in Japan, medical director of Hanabusa Women’s Clinic, and Dr. Lyndon Chang, the director of Hanabusa IVF in the United States, were invited to participate. Dr. Hui Shao, the inventor of Shawkea products, shared the "Clinical Application of Shawkea T-1 to Increase the Pregnancy Rate of Female Patients.”
Between March 1-3, 2019, the National Medical Continuing Education Project "Reproductive Endocrinology Frontiers and New Progress of Clinical Research Seminar" was successfully held. It was co-sponsored by the Guangdong Provincial Medical Association's Obstetricians and Gynecologists Branch and Sun Yixian Memorial Hospital of Sun Yixian University in Guangzhou. This conference received great attention from the industry. Sina, Tencent Video, Youku and other media outlets conducted follow-up reports and interviews. Shawkea product inventor, Dr. Hui Shao was invited to participate and gave a speech on "Repeated IVF Failure in Older Patients".
Product Qualification
High-standard safety and quality control is the goal of Shawkea products.. We always prioritize safety and quality, and do not overlook any factors that may potentially endanger the safety or quality of the products.Products are subject to independent and third-party testing by authoritative institutions authorized by Japan’s government. Tests include acute toxicity, chronic toxicity, chromosomal abnormality, allergen, heavy metals, preservatives, bleach, Gram-positive and Gram-negative bacteria, 630 kinds of pesticide residues, etc. Shawkea products successfully passed all the tests. The manufacturing base of Shawkea products is GMP and HACCP certified. The entire production process strictly adheres to protocols and regulations to ensure product quality and safety during manufacture.
